非洲裔美国人移植接入计划:缓解固体器官移植的差异
Dinee C Simpson1, Joy E Obayemi2, Kiarri N Kershaw3
1Northwestern Medicine Health Care, Chicago, Illinois, USA; Associate Professor of Surgery, Division of Transplant, Northwestern University Feinberg School of Medicine, Northwestern University Transplant Outcomes Research Collaborative (NUTORC), Chicago, Illinois, USA; Founding Director, African American Transplant Access Program, Comprehensive Transplant Center, Chicago, Illinois, USA.
NEJM catalyst innovations in care delivery
|November 1, 2024
概括
黑人美国人面临更高的末期病率 (ESKD) 和减少移植的机会. 一个新的非裔美国人移植接入计划 (AATAP) 提供了一个文化一致的解决方案,以改善这一群体的移植接入.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 移植免疫学 移植免疫学
- 健康差距 研究 研究 研究 研究
背景情况:
- 黑人美国人经历末期病 (ESKD) 在不成比例地更高的率.
- 移植为ESKD提供了最好的结果,但黑人患者面临的机会减少.
- 结构性和制度性障碍导致黑人患者在移植的机会上存在很大的差异.
研究的目的:
- 总结有关黑人患者移植差异的现有文献.
- 提出一种新的,实际的解决方案,以改善黑人美国人的移植机会.
- 引入非洲裔美国人移植接入计划 (AATAP) 和其框架.
主要方法:
- 关于黑人患者在脏移植中的差异的文献综述.
- 非洲裔美国人移植接入计划 (AATAP) 的概念化和详细概述.
- 描述AATAP的支柱:文化一致性,信任,健康素养和心理社会支持.
主要成果:
- 该AATAP计划旨在解决黑人患者面临的结构和机构障碍.
- 初步结果表明,该计划有可能改善移植机会.
- 为建立类似的文化一致的移植接入计划提供了指导.
结论:
- 文化一致的项目对于克服黑人患者移植获取障碍至关重要.
- AATAP模型提供了一个切实可行的框架,用于减少移植中的种族差异.
- 进一步实施此类计划可以改善ESKD的黑人美国人的结果.
相关概念视频
01:24Tissue Transplantation
341
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
341
01:22Bone Marrow Sampling and Transplants
292
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
292